Trades on 1 secondary market
Carrick Therapeutics
Carrick Therapeutics is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, developing novel oncology therapies aimed at improving outcomes for patients with aggressive and treatment-resistant cancers. Its pipeline centers on transcriptional CDK inhibition, led by samu
Carrick Therapeutics is an API provider whose private shares are listed on 1 secondary market: EquityZen.
Where It Trades
Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.